NuCana (NCNA) Retained Earnings (2016 - 2025)
NuCana's (NCNA) quarterly Retained Earnings came in at $115.8 million in Q4 2025, up 15.07% year-on-year from $100.7 million in Q4 2024, and down 0.88% quarter-over-quarter from $116.9 million in Q3 2025.
NuCana (NCNA) Retained Earnings (2016 - 2025) Analysis & Trends
NuCana has disclosed Retained Earnings across 10 years of filings, most recently posting $115.8 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at $115.8 million, up 15.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $115.8 million (up 15.07% YoY), and the FY2025 annual result was $114.8 million, up 14.53% from the prior year.
- Retained Earnings came in at $115.8 million for Q4 2025 at NuCana, down from $116.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $116.9 million in Q3 2025 to a low of $88.5 million in Q3 2022.
- The 5-year median for Retained Earnings is $98.4 million (2022), against an average of $99.6 million.
- Across the five-year window, Retained Earnings advanced 21.06% in 2021 and retreated 8.84% in 2022, its largest moves.
- NuCana's Retained Earnings stood at $97.2 million in 2021, then fell by 8.48% to $89.0 million in 2022, then climbed by 10.42% to $98.3 million in 2023, then increased by 2.43% to $100.7 million in 2024, then climbed by 15.07% to $115.8 million in 2025.
- The last three Retained Earnings figures came in at $115.8 million (Q4 2025), $116.9 million (Q3 2025), and $115.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 115.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 115.82 Mn |
| Sep 30, 2025 | 116.85 Mn |
| Jun 30, 2025 | 115.27 Mn |
| Mar 31, 2025 | 99.01 Mn |
| Dec 31, 2024 | 100.65 Mn |
| Sep 30, 2024 | 101.87 Mn |
| Jun 30, 2024 | 98.92 Mn |
| Mar 31, 2024 | 101.02 Mn |
| Dec 31, 2023 | 98.27 Mn |
| Sep 30, 2023 | 99.35 Mn |
| Jun 30, 2023 | 97.24 Mn |
| Mar 31, 2023 | 93.48 Mn |
| Dec 31, 2022 | 88.99 Mn |
| Sep 30, 2022 | 88.47 Mn |
| Jun 30, 2022 | 94.00 Mn |
| Mar 31, 2022 | 98.60 Mn |
| Dec 31, 2021 | 97.24 Mn |
| Sep 30, 2021 | 97.05 Mn |
| Jun 30, 2021 | 96.74 Mn |
| Mar 31, 2021 | 93.04 Mn |